The protein encoded by the FOLH1 gene is commonly referred to as PSMA in the oncology community. However, neurological and metabolic studies describe FOLH1 as glutamate carboxypeptidase II (GCPII) or N-acetyl-L-aspartyl-L-glutamate peptidase I (NAALA-Dase I). Setting aside nomenclature differences, this enzyme — PSMA, GCPII or NAALADase I — functions as a transmembrane glycoprotein with both folate hydrolase and carboxypeptidase capabilities. This protein is predominantly expressed in the prostate gland, renal tissue and duodenum, where it has a vital role in the enzymatic processing of dietary folates. Structurally, PSMA consists of a 19-amino-acid intracellular portion, a 24-amino-acid transmembrane portion, and a 707-amino-acid extracellular portion.